CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 251 enrolled
Drug / intervention
Home Respiratory Polygraphy (APNIA) +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03415633
NCT03415633N/ACompleted
CompareCT.gov

Validity and Cost-effectiveness Analysis of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea

Hospital Universitario Araba·interventional·Posted Jan 30, 2018·Updated Sep 6, 2018

In Brief

A clinical study evaluating Home Respiratory Polygraphy (APNIA) and Standard Polysomnography (PSG) for Obstructive Sleep Apnea (OSA). Completed, enrolled 251 participants across 1 site.

Detailed Summary

To assess the diagnostic validity and cost-effectiveness of a APNiA device, a home respiratory polygraphy (HRP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea (OSA)
CountriesSpain
CollaboratorsBTI Biotechnology Institute S.L, Instituto de Investigación Sanitaria BIO-ARABA

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 30, 2018
Enrollment StartSep 1, 2015
Primary CompletionJun 1, 2018
Study CompletionSep 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 8.4 years ago

Interventions

Home Respiratory Polygraphy (APNIA)other

Randomizing to start with home respiratory polygraphy (APNIA)

Standard Polysomnography (PSG)other

Randomizing to start with Standard Polysomnography (PSG)

Home Respiratory Polygraphy (APNIA)other

Randomizing for therapeutic decision taken with home respiratory polygraphy (APNIA)

Standard Polysomnography (PSG)other

Randomizing for therapeutic decision taken with Standard Polysomnography (PSG)